Overview

The Efficacy and Neurobehavioural Mechanism of N-acetyl Cysteine (NAC) for Alcohol Dependence

Status:
Unknown status
Trial end date:
2020-11-01
Target enrollment:
Participant gender:
Summary
The study will explore the efficacy and tolerability of a regimen of NAC (2400 mg) versus placebo for the treatment of alcohol dependence.
Phase:
Phase 2
Details
Lead Sponsor:
South West Sydney Local Health District
Collaborators:
National Health and Medical Research Council, Australia
University of Sydney
Treatments:
Acetylcysteine
N-monoacetylcystine